Business Wire

Saray Capital: Focused and Disciplined Value Investors from the Lands of Arabia

Del

The following is a statement from Saray Capital

Approaching the last quarter of 2016 – we are faced with two general market conditions in our two geographical focus areas – the Middle East North Africa (MENA) markets and the developed markets.

The MENA markets fell significantly in recent months as result of factors ranging from political uncertainties or in the case of the Gulf Cooperation Council countries the severe oil price crash.
These macro issues started to affect the wider economy and the consumer as the GCC countries switched from having budget surpluses to budget deficits and from overspending to budget cuts severely slowing economic activity and drying up liquidity in the markets.
Almost a perfect storm of pessimism appeared overwhelming individuals corporates and financial institutions.
The negative spiral continued as fear drove people to take sometimes emotional decisions to sell their most liquid investments – stocks - and convert their assets to the psychological safety of cash ,meanwhile margin calls pushed liquidations of portfolios causing further lowering of share prices as exemplified by the regional indexes losing close to 39% of their value since the fourth quarter of 2014.

More specifically, Saudi Arabia stocks exhibited a more drastic decline as the Tadwul index lost more than half of its value from the fourth quarter of 2014. Although further declines could occur and contrary to the dominating negative sentiment, we believe that current prices provide good risk adjusted low valuations enabling us to purchase parts of leading businesses in Saudi and the region that will survive the current downturn and potentially thrive thereafter due to the fact that these companies possess superior financial standings, solid market positions, as well as good management.

Furthermore, an added critical reason that is giving us comfort to invest in these uncertain times selectively in the MENA region stems from our belief that oil will still be an important commodity and source of fuel for decades to come and the exaggerated story of the end of oil or oversupply of oil is not to be believed fully especially in the short to medium term.

On the contrary, in the developed markets the situation is quite different. As a result of the massive programs to infuse liquidity into the system, historical all time highs prices of bonds and equities were reached creating unhealthy environments exemplified by assets in the trillions of dollars paying owners a negative yield. This situation has lead us unfortunately to find no value in some of the largest markets such as the US and Germany, currently. However, other parts of the developed markets are experiencing turbulence and volatility from the expected continued slowdown of China and Brexit complications - creating certain value opportunities.

At Saray Capital we believe that emotions dominate in the short term however facts rule over the long term. Coming from a region that has the oldest recorded commercial transactions in history dating more than five thousand years ago, we believe that economic and political cycles are a natural phenomenon and to be expected and to be prepared for by always being disciplined, diversified across geographies and asset classes, and under-leveraged.

Moreover, the founders of Saray Capital due to their experience as well as merchant families heritage practice holding concentrated number of well researched investments for the long term. It is a private equity and merchant families approach to investing in the public markets.

We believe that in order to safeguard and grow capital for our investors it is exactly at such volatile times that we step in to purchase highly selected, high barrier to entry, financially healthy, high quality companies sometimes offered at historical low valuations in the regions that we currently find value in parts of developed Asia, the UK, Europe, and in the MENA markets mainly the GCC and Turkey.

Finally, we at Saray believe in and practice true and full alignment by investing our own capital alongside our investors. At Saray Capital, we are compensated purely on a success fee basis and hence only benefit when our investors benefit first.

Contact information

Saray Capital
Magued Hanna, Tel: +97152 612 9993
info@saraycapital.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom